�ݺ�ߣshows by User: gtarunreddy

�ݺ�ߣshows by User: gtarunreddy / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: gtarunreddy / Sat, 11 Jul 2020 05:34:10 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: gtarunreddy Regulatory Affairs role in Pharmaceutical Industry /slideshow/regulatory-affairs-role-in-pharmaceutical-industry/236804587 regulatoryaspects-200711053410
The dossier is a collection of documents that contain all the technical data of pharmaceutical products to be approved\ registered\ marketed in a country. ]]>
The dossier is a collection of documents that contain all the technical data of pharmaceutical products to be approved\ registered\ marketed in a country. ]]> Sat, 11 Jul 2020 05:34:10 GMT /slideshow/regulatory-affairs-role-in-pharmaceutical-industry/236804587 gtarunreddy@slideshare.net(gtarunreddy) Regulatory Affairs role in Pharmaceutical Industry gtarunreddy The dossier is a collection of documents that contain all the technical data of pharmaceutical products to be approved\ registered\ marketed in a country. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/regulatoryaspects-200711053410-thumbnail.jpg?width=120&height=120&fit=bounds" /> The dossier is a collection of documents that contain all the technical data of pharmaceutical products to be approved\ registered\ marketed in a country.

Regulatory Affairs role in Pharmaceutical Industry from Tarun Kumar Reddy

]]> 1879 0 https://cdn.slidesharecdn.com/ss_thumbnails/regulatoryaspects-200711053410-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Formulation and evaluation of nanoparticles as a drug delivery systems /slideshow/formulation-and-evaluation-of-nanoparticles-as-a-drug-delivery-systems/236750268 formulationandevaluationofnanoparticlesasadrugdeliverysystems-200709123517
Nanomaterials fall into a size range similar to proteins and other macromolecular structures found inside living cells. As such, nanomaterials are poised to take advantage of existing cellular machinery to facilitate the delivery of drugs. Nanoparticles containing encapsulated, dispersed, absorbed or conjugated drugs have unique characteristics that can lead to enhanced performance in a variety of dosage forms.]]>
Nanomaterials fall into a size range similar to proteins and other macromolecular structures found inside living cells. As such, nanomaterials are poised to take advantage of existing cellular machinery to facilitate the delivery of drugs. Nanoparticles containing encapsulated, dispersed, absorbed or conjugated drugs have unique characteristics that can lead to enhanced performance in a variety of dosage forms.]]> Thu, 09 Jul 2020 12:35:17 GMT /slideshow/formulation-and-evaluation-of-nanoparticles-as-a-drug-delivery-systems/236750268 gtarunreddy@slideshare.net(gtarunreddy) Formulation and evaluation of nanoparticles as a drug delivery systems gtarunreddy Nanomaterials fall into a size range similar to proteins and other macromolecular structures found inside living cells. As such, nanomaterials are poised to take advantage of existing cellular machinery to facilitate the delivery of drugs. Nanoparticles containing encapsulated, dispersed, absorbed or conjugated drugs have unique characteristics that can lead to enhanced performance in a variety of dosage forms. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/formulationandevaluationofnanoparticlesasadrugdeliverysystems-200709123517-thumbnail.jpg?width=120&height=120&fit=bounds" /> Nanomaterials fall into a size range similar to proteins and other macromolecular structures found inside living cells. As such, nanomaterials are poised to take advantage of existing cellular machinery to facilitate the delivery of drugs. Nanoparticles containing encapsulated, dispersed, absorbed or conjugated drugs have unique characteristics that can lead to enhanced performance in a variety of dosage forms.

Formulation and evaluation of nanoparticles as a drug delivery systems from Tarun Kumar Reddy

]]> 2196 0 https://cdn.slidesharecdn.com/ss_thumbnails/formulationandevaluationofnanoparticlesasadrugdeliverysystems-200709123517-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 National Drug Policy /gtarunreddy/national-drug-policy-236738739 nationaldrugpolicy-200709043154
National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices.]]>
National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices.]]> Thu, 09 Jul 2020 04:31:54 GMT /gtarunreddy/national-drug-policy-236738739 gtarunreddy@slideshare.net(gtarunreddy) National Drug Policy gtarunreddy National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nationaldrugpolicy-200709043154-thumbnail.jpg?width=120&height=120&fit=bounds" /> National Drug Policy shall focus on effective drug management processes, such as rational drug selection, proper quantification of drug needs at all levels of health care delivery, and effective procurement practices.

National Drug Policy from Tarun Kumar Reddy

]]> 3106 0 https://cdn.slidesharecdn.com/ss_thumbnails/nationaldrugpolicy-200709043154-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Prescription Drug User Fee Act /slideshow/prescription-drug-user-fee-act-236720894/236720894 prescriptiondruguserfeeact-200708161337
The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. PDUFA has had a significant role in modern drug review at FDA. Before PDUFA, FDA's review process was understaffed, unpredictable and slow. FDA lacked sufficient staff to perform timely reviews or develop procedures and standards to make the process more rigorous, consistent, and predictable. FDA lacked the funds to provide computers to all FDA reviewers.]]>
The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. PDUFA has had a significant role in modern drug review at FDA. Before PDUFA, FDA's review process was understaffed, unpredictable and slow. FDA lacked sufficient staff to perform timely reviews or develop procedures and standards to make the process more rigorous, consistent, and predictable. FDA lacked the funds to provide computers to all FDA reviewers.]]> Wed, 08 Jul 2020 16:13:37 GMT /slideshow/prescription-drug-user-fee-act-236720894/236720894 gtarunreddy@slideshare.net(gtarunreddy) Prescription Drug User Fee Act gtarunreddy The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. PDUFA has had a significant role in modern drug review at FDA. Before PDUFA, FDA's review process was understaffed, unpredictable and slow. FDA lacked sufficient staff to perform timely reviews or develop procedures and standards to make the process more rigorous, consistent, and predictable. FDA lacked the funds to provide computers to all FDA reviewers. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/prescriptiondruguserfeeact-200708161337-thumbnail.jpg?width=120&height=120&fit=bounds" /> The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. PDUFA has had a significant role in modern drug review at FDA. Before PDUFA, FDA's review process was understaffed, unpredictable and slow. FDA lacked sufficient staff to perform timely reviews or develop procedures and standards to make the process more rigorous, consistent, and predictable. FDA lacked the funds to provide computers to all FDA reviewers.

Prescription Drug User Fee Act from Tarun Kumar Reddy

]]> 244 0 https://cdn.slidesharecdn.com/ss_thumbnails/prescriptiondruguserfeeact-200708161337-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Medical devices /slideshow/medical-devices-80856074/80856074 dan5osedtwoyxnl03lme-signature-c65919d299b75298be909aad8bd20088121c392dad84700702ce0252743bfebe-poli-171016122629
To comprehend the regulatory requirements to import medical Medical devices and authorization procedures in regulated markets of the United States and Australia ]]>
To comprehend the regulatory requirements to import medical Medical devices and authorization procedures in regulated markets of the United States and Australia ]]> Mon, 16 Oct 2017 12:26:29 GMT /slideshow/medical-devices-80856074/80856074 gtarunreddy@slideshare.net(gtarunreddy) Medical devices gtarunreddy To comprehend the regulatory requirements to import medical Medical devices and authorization procedures in regulated markets of the United States and Australia <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/dan5osedtwoyxnl03lme-signature-c65919d299b75298be909aad8bd20088121c392dad84700702ce0252743bfebe-poli-171016122629-thumbnail.jpg?width=120&height=120&fit=bounds" /> To comprehend the regulatory requirements to import medical Medical devices and authorization procedures in regulated markets of the United States and Australia

Medical devices from Tarun Kumar Reddy

]]> 5996 13 https://cdn.slidesharecdn.com/ss_thumbnails/dan5osedtwoyxnl03lme-signature-c65919d299b75298be909aad8bd20088121c392dad84700702ce0252743bfebe-poli-171016122629-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Metformin hydrochloride /slideshow/metformin-hydrochloride/60735624 metforminhydrochloride-160411042132
Formulation and evaluation of METFORMIN HCL sustained release tabs... ]]>
Formulation and evaluation of METFORMIN HCL sustained release tabs... ]]> Mon, 11 Apr 2016 04:21:32 GMT /slideshow/metformin-hydrochloride/60735624 gtarunreddy@slideshare.net(gtarunreddy) Metformin hydrochloride gtarunreddy Formulation and evaluation of METFORMIN HCL sustained release tabs... <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/metforminhydrochloride-160411042132-thumbnail.jpg?width=120&height=120&fit=bounds" /> Formulation and evaluation of METFORMIN HCL sustained release tabs...

Metformin hydrochloride from Tarun Kumar Reddy

]]> 6016 10 https://cdn.slidesharecdn.com/ss_thumbnails/metforminhydrochloride-160411042132-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Nda and Anda /slideshow/nda-and-anda-56228771/56228771 ndaandandappt2-151217062919
Brief presentation about the Nda and Anda filling processes]]>
Brief presentation about the Nda and Anda filling processes]]> Thu, 17 Dec 2015 06:29:19 GMT /slideshow/nda-and-anda-56228771/56228771 gtarunreddy@slideshare.net(gtarunreddy) Nda and Anda gtarunreddy Brief presentation about the Nda and Anda filling processes <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ndaandandappt2-151217062919-thumbnail.jpg?width=120&height=120&fit=bounds" /> Brief presentation about the Nda and Anda filling processes

Nda and Anda from Tarun Kumar Reddy

]]> 5295 6 https://cdn.slidesharecdn.com/ss_thumbnails/ndaandandappt2-151217062919-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Xrd /slideshow/xrd-56228561/56228561 xrd-151217061529
How to interpret (tally) the XRD data ]]>
How to interpret (tally) the XRD data ]]> Thu, 17 Dec 2015 06:15:28 GMT /slideshow/xrd-56228561/56228561 gtarunreddy@slideshare.net(gtarunreddy) Xrd gtarunreddy How to interpret (tally) the XRD data <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/xrd-151217061529-thumbnail.jpg?width=120&height=120&fit=bounds" /> How to interpret (tally) the XRD data

Xrd from Tarun Kumar Reddy

]]> 4717 7 https://cdn.slidesharecdn.com/ss_thumbnails/xrd-151217061529-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Pharmacognosy a quick review /slideshow/parrmacognosy-a-quick-review/45590781 parrmacognosyaquickreview-150308231912-conversion-gate01
It is a detail view on medicinal plants.]]>
It is a detail view on medicinal plants.]]> Sun, 08 Mar 2015 23:19:12 GMT /slideshow/parrmacognosy-a-quick-review/45590781 gtarunreddy@slideshare.net(gtarunreddy) Pharmacognosy a quick review gtarunreddy It is a detail view on medicinal plants. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/parrmacognosyaquickreview-150308231912-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds" /> It is a detail view on medicinal plants.

Pharmacognosy a quick review from Tarun Kumar Reddy

]]> 16339 14 https://cdn.slidesharecdn.com/ss_thumbnails/parrmacognosyaquickreview-150308231912-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://public.slidesharecdn.com/v2/images/profile-picture.png www.linkedin.com/in/tarun-kumar-reddy/ https://cdn.slidesharecdn.com/ss_thumbnails/regulatoryaspects-200711053410-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/regulatory-affairs-role-in-pharmaceutical-industry/236804587 Regulatory Affairs rol... https://cdn.slidesharecdn.com/ss_thumbnails/formulationandevaluationofnanoparticlesasadrugdeliverysystems-200709123517-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/formulation-and-evaluation-of-nanoparticles-as-a-drug-delivery-systems/236750268 Formulation and evalua... https://cdn.slidesharecdn.com/ss_thumbnails/nationaldrugpolicy-200709043154-thumbnail.jpg?width=320&height=320&fit=bounds gtarunreddy/national-drug-policy-236738739 National Drug Policy